HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC125-C203: Phase II Randomized (Patients Are Assigned Different Treatments Based on Chance), Placebo Controlled Dose Escalating Trial of TMC125 in HIV-1 Infected Patients [Phase 2]
Phase II randomized, placebo-controlled, dose-escalation trial of TMC125 (dapivirine) in HIV-1 infected patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function. [Phase 1]
Phase 1 PK and safety study assessing rilpivirine (TMC278) in HIV patients with mild-to-moderate hepatic impairment; focuses on pharmacokine…
-
CLINICAL_TRIALS trial_result · 2010-04-28Clinical Trial Update: TMC278-TiDP6-C121: Drug-drug Interaction Trial to Investigate the Potential Interaction Between TMC278 25 mg Daily and Methadone, at Steady State. [Phase 1]
Phase 1 trial evaluating potential drug-drug interaction between rilpivirine (TMC278) 25 mg daily and methadone at steady state in HIV-infec…
-
FDA approval · 2010-04-27FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) by AbbVie Inc.
-
FDA approval · 2010-04-27FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir and ritonavir) submitted by AbbVie Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2010-04-27FDA Approved: APTIVUS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
The FDA approved a supplemental application for APTIVUS (tipranavir) submitted by Boehringer Ingelheim Pharmaceuticals, indicating additiona…
-
FDA approval · 2010-04-26FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C., approving changes to the existing …
-
FDA approval · 2010-04-26FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron, to the existing NDA NDA020779.
-
FDA approval · 2010-04-26FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)
The FDA approved a supplemental application for PREZISTA (darunavir) submitted by Janssen Products LP, updating the labeling as part of the …
-
FDA approval · 2010-04-26FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approves a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron.
-
CLINICAL_TRIALS trial_result · 2010-04-26Clinical Trial Update: Long-Term Effects of HAART in Youth With Stronger Immune Systems Versus Youth With Weaker Immune Systems
A completed study comparing long-term effects of HAART in youths with stronger immune systems versus youths with weaker immune systems.
-
CLINICAL_TRIALS trial_result · 2010-04-23Clinical Trial Update: Breastfeeding, Antiretroviral, and Nutrition Study [Phase 3]
Phase 3 clinical trial sponsored by the CDC investigating breastfeeding, antiretroviral therapy, and nutrition in HIV infection has complete…
-
CLINICAL_TRIALS trial_result · 2010-04-21Clinical Trial Update: Acupressure to Treat Nausea and Vomiting in HIV/AIDS Patients [Phase 1]
Phase 1 trial evaluating acupressure to treat nausea and vomiting in HIV/AIDS patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-04-14Clinical Trial Update: Study of Home-Based Resistance and Strength Training in HIV-Infected Women [NA]
This ClinicalTrials.gov entry reports a completed study evaluating a home-based resistance and strength training program in HIV-infected wom…
-
CLINICAL_TRIALS research · 2010-04-14Clinical Trial Update: Pharmacotherapy for HIV+ Stimulant Dependent Individuals [NA]
An ongoing clinical trial evaluating pharmacotherapy for HIV-positive individuals with stimulant dependence. Current status of the study is …
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: Safety and Efficacy of an Investigational Drug in Human Immunodeficiency Virus (HIV)-Infected Patients Failing Current Antiretroviral Therapies (0518-005)(COMPLETED) [Phase 2]
Phase 2 trial assessing safety and efficacy of an investigational HIV drug in patients failing current antiretroviral therapy, with results …
-
CLINICAL_TRIALS trial_result · 2010-04-12Clinical Trial Update: A Study to Evaluate the Pharmacokinetic Profile (How the Body Absorbs, Distributes, Metabolizes and Eliminates a Drug) of TMC125 Plus Tenofovir/Emtricitabine Once Daily With or Without Darunavir/r Once Daily in Antiretroviral (ARV) Naive HIV-1 Patients (Patients Have Never Received ARV Treatment). [Phase 2]
This Phase 2 pharmacokinetic study evaluated how etravirine (TMC125) plus tenofovir/emtricitabine, with or without boosted darunavir/ritonav…
-
CLINICAL_TRIALS research · 2010-04-08Clinical Trial Update: (Men Who Have Sex With Men) MSM Community Intervention Trial [Phase 3]
A Phase 3 clinical trial update from China evaluating a MSM community intervention to reduce HIV and syphilis transmission; the status is li…
-
CLINICAL_TRIALS research · 2010-04-01Clinical Trial Update: A Phase 2 Study to Assess the Pharmacokinetics of Bevirimat 100 mg Tablets Given to HIV-1 Positive Patient for 15 Days [Phase 2]
A Phase 2 pharmacokinetic study of Bevirimat 100 mg tablets in HIV-1 infected individuals has completed.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Switching From PI to RALtegravir in HIV Stable Patients [Phase 3]
Phase 3 trial updated results on switching from protease inhibitors to raltegravir in HIV-infected patients stable on therapy; study has com…
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis [Phase 4]
This document reports the completion status of a Phase 4 trial evaluating Atazanavir or Lopinavir for HIV post-exposure prophylaxis.
-
CLINICAL_TRIALS trial_result · 2010-03-31Clinical Trial Update: Integrase Resistance Analysis in HIV Patients Who Interrupted Raltegravir Due to Incomplete Viral Suppression [NA]
This clinical trial update analyzes integrase resistance in HIV-infected patients who interrupted raltegravir due to incomplete viral suppre…
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED) [Phase 2]
The document reports the completed Phase 2 study assessing the safety and efficacy of an investigational drug in HIV-infected patients, with…
-
CLINICAL_TRIALS trial_result · 2010-03-29Clinical Trial Update: Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings [NA]
This document provides an update on a completed clinical trial evaluating the effectiveness of directly observed therapy for combined HIV an…
-
FDA approval · 2010-03-26FDA Approved: ISENTRESS — Supplemental Application (Merck Sharp & Dohme LLC)
FDA approved a supplemental application for ISENTRESS (raltegravir) submitted by Merck Sharp & Dohme LLC.